Detection of mRNA Transcripts and Active Transcription in Persistent Mycobacterium tuberculosisInduced by Exposure to Rifampin or Pyrazinamide

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Bacteriology

• Publication date

  2000-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JB.182.22.6358-6365.2000PMID 11053379PMCID PMC94781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

  2015influential reference
• The global tuberculosis situation and the new control strategy of the World Health Organization. 1991.

  2001cited by this paper
• Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA.

  2000cited by this paper
• Role of individual drugs in the chemotherapy of tuberculosis.

  2000cited by this paper
• The death and resurrection of tuberculosis

  1999cited by this paper
• Transcription of the Stationary-Phase-AssociatedhspX Gene of Mycobacterium tuberculosis Is Inversely Related to Synthesis of the 16-Kilodalton Protein

  1999cited by this paper
• Therapy of tuberculosis in mice by DNA vaccination

  1999cited by this paper
• Quantitative Analysis of mRNA as a Marker for Viability of Mycobacterium tuberculosis

  1999cited by this paper
• Transcription of Two Sigma 70 Homologue Genes,sigA and sigB, in Stationary-PhaseMycobacterium tuberculosis

  1999cited by this paper
• Intracellular Gene Expression

  1998cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• O 157 : H 7 coli Escherichia and Staphylococcus aureus UV-Irradiated Enterotoxigenic rRNA Stability in Heat-Killed and

  1998cited by this paper
• Detection of mRNA by Reverse Transcription-PCR as an Indicator of Viability in Escherichia coliCells

  1998cited by this paper
• Differential inhibition of transcription from σ70‐ and σ32‐dependent promoters by rifampicin

  1998cited by this paper
• Mycobacterial Stationary Phase Induced by Low Oxygen Tension: Cell Wall Thickening and Localization of the 16-Kilodalton α-Crystallin Homolog

  1998cited by this paper
• Mechanisms of latency in Mycobacterium tuberculosis.

  1998cited by this paper
• Erratum: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

  1998cited by this paper
• rRNA Stability in Heat-Killed and UV-Irradiated EnterotoxigenicStaphylococcus aureus and Escherichia coliO157:H7

  1998cited by this paper
• Intracellular gene expression. Analysis of RNA from mycobacteria in macrophages using RT-PCR.

  1998cited by this paper
• Differential inhibition of transcription from sigma70- and sigma32-dependent promoters by rifampicin.

  1998cited by this paper
• Salmonella DNA persistence in natural seawaters using PCR analysis

  1997cited by this paper
• An effective method of RNA extraction from bacteria refractory to disruption, including mycobacteria.

  1997cited by this paper
• Detection of viable and deadListeria monocytogenesby PCR

  1997cited by this paper
• Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog

  1996cited by this paper
• A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis.

  1996cited by this paper
• The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis.

  1995cited by this paper
• Mycobacterial dormancy.

  1995cited by this paper
• Genomic organization of the mycobacterial sigma gene cluster.

  1995cited by this paper
• Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

  1994cited by this paper
• Effect of stress treatments on the detection of Listeria monocytogenes and enterotoxigenic Escherichia coli by the polymerase chain reaction.

  1994cited by this paper
• Assessment of mycobacterial viability by RNA amplification

  1994cited by this paper
• Determination of Mycobacterium leprae viability by polymerase chain reaction amplification of 71-kDa heat-shock protein mRNA.

  1993cited by this paper
• The mystery of the mycobacterial 'persistor'.

  1992cited by this paper
• Identification of a central regulator of stationary‐phase gene expression in Escherichia coli

  1991cited by this paper
• The global tuberculosis situation and the new control strategy of the World Health Organization.

  1991cited by this paper
• CYTOTOXIC CHEMOTHERAPY IN BREAST CANCER

  1985cited by this paper
• Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.

  1981cited by this paper
• Whither short-course chemotherapy?

  1981cited by this paper
• First-line chemotherapy in the retreatment of bacteriological relapses of pulmonary tuberculosis following a shortcourse regimen.

  1976cited by this paper
• MICROBIAL PERSISTENCE

  1966cited by this paper
• Statistical Tables for Biological, Agricultural and Medical Research

  1956cited by this paper
• The bactericidal activities of antituberculous drugs.

  1956cited by this paper
• Statistical Tables: For Biological, Agricultural and Medical Research

  1954influential reference
• Statistical Tables for Biological Agricultural and Medical Research

  1939cited by this paper
• Statistical tables for biological, agricultural aad medical research.

  1938cited by this paper

• Exploring the Protein Landscape of Dormant Mycobacterium tuberculosis Through In Vitro Functional Studies.

  2026cites this paper
• Incorporation of macrophage immune stresses into an intracellular assay of drug tolerance in Mycobacterium tuberculosis

  2025cites this paper
• Incorporation of macrophage immune stresses into an assay for drug tolerance in intracellular Mycobacterium tuberculosis

  2025cites this paper
• Insights into Mycobacterium abscessus survival under prolonged potassium deficiency and starvation

  2025cites this paper
• Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance

  2024cites this paper
• Unveiling the orchestration: mycobacterial small RNAs as key mediators in host-pathogen interactions

  2024cites this paper
• The use of Mycobacterium tuberculosis H37Ra-infected immunocompetent mice as an in vivo model of persisters.

  2024cites this paper
• Small RNA MTS1338 Configures a Stress Resistance Signature in Mycobacterium tuberculosis

  2023cites this paper
• Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the bacilli.

  2023cites this paper
• Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis

  2022cites this paper
• Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger

  2022cites this paper
• Clinically encountered growth phenotypes of tuberculosis-causing bacilli and their in vitro study: A review

  2022cites this paper
• Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India.

  2022cites this paper
• Detection of viable Mycobacterium tuberculosis in ocular fluids using mRNA-based multiplex polymerase chain reaction.

  2022cites this paper
• Polycationic Glycopolymer Demonstrates Activity Against Persisters and Biofilms of Non-tuberculosis Mycobacteria Cystic Fibrosis Clinical Isolates in vitro

  2022cites this paper
• Are all antibiotic persisters created equal?

  2022cites this paper
• Diagnostic Accuracy of Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: A Systematic Review with Meta-Analysis

  2021cites this paper
• RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria

  2021cites this paper
• Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?

  2021cites this paper
• Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis

  2021cites this paper
• Long non-coding RNAs ENST00000429730.1 and MSTRG.93125.4 are associated with metabolic activity in tuberculosis lesions of sputum-negative tuberculosis patients

  2021cites this paper
• Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)

  2021cites this paper
• Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected

  2021cites this paper
• Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases

  2021cites this paper
• Drug-Resistant Tuberculosis 2020: Where We Stand

  2020cites this paper
• Drug Resistance Mechanisms In Tuberculosis | Encyclopedia

  2020cites this paper
• FDG-PET in Treatment Response Assessment of Tuberculosis

  2020cites this paper
• Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis

  2020cites this paper
• PET/CT in Tuberculosis

  2020cites this paper
• A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis

  2020cites this paper
• Imaging Tuberculosis and AIDS Associated Infections

  2019cites this paper
• Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis

  2019cites this paper
• PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS

  2019cites this paper
• Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.

  2019cites this paper
• Eliminating Mycobacterial Persistence: Novel Targets for Anti-TB Therapy

  2019cites this paper
• Unveiling the physiological mechanisms that drive the emergence of antibiotic resisters from antibiotic persister population of mycobacteria

  2019cites this paper
• MTS1338, A Small Mycobacterium tuberculosis RNA, Regulates Transcriptional Shifts Consistent With Bacterial Adaptation for Entering Into Dormancy and Survival Within Host Macrophages

  2019cites this paper
• Mycobacterium smegmatis moxifloxacin persister cells produce high levels of hydroxyl radical, generating genetic resisters selectable not only with moxifloxacin, but also with ethambutol and isoniazid.

  2019cites this paper
• 18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis

  2019cites this paper
• Generality of Post-Antimicrobial Treatment Persistence of Borrelia burgdorferi Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains

  2019cites this paper
• The generality of post-antimicrobial treatment persistence of replicatively-attenuated Borrelia burgdorferi in a mouse model

  2019cites this paper
• Effect of various drugs on differentially detectable persisters of Mycobacterium tuberculosis generated by long-term lipid diet.

  2019cites this paper
• Differential Expression of Proteins of Mycobacterium bovis BCG during Adaptation to Anaerobic Non Replicating Persistence

  2018cites this paper
• Phenotypic discrimination of Mycobacterium tuberculosis by Raman spectroscopy

  2018cites this paper
• Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria

  2018cites this paper
• Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs

  2018cites this paper
• Characterization and Transcriptome Analysis of Acinetobacter baumannii Persister Cells

  2018cites this paper
• The potential of imaging tools as correlates of infection and disease for new TB vaccine development.

  2018cites this paper
• A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images

  2018cites this paper
• Challenges associated with the treatment of Buruli ulcer

  2018cites this paper
• Impacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases

  2018cites this paper
• Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

  2018cites this paper
• Molecular Mechanisms of Dormancy and Resuscitation

  2017cites this paper
• Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations

  2017cites this paper
• Mechanisms of Drug Action, Drug Resistance and Drug Tolerance in Mycobacterium tuberculosis: Expected Phenotypes from Evolutionary Pressures from a Highly Successful Pathogen

  2017cites this paper
• Tuberculosis "the great imitator": False healing and subclinical activity.

  2017cites this paper
• Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

  2017cites this paper
• Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay

  2017cites this paper
• Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli

  2017cites this paper
• Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level

  2016cites this paper
• Multidrug Resistance in Mycobacteria

  2016cites this paper
• Modelling the effects of bacterial cell state and spatial location on tuberculosis treatment: Insights from a hybrid multiscale cellular automaton model

  2016cites this paper
• Defining dormancy in mycobacterial disease.

  2016influential citation
• Novel Pharmacometric Methods for Informed Tuberculosis Drug Development

  2016influential citation
• Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis

  2016cites this paper
• Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model

  2016cites this paper
• The Making and Taking of Lipids: The Role of Bacterial Lipid Synthesis and the Harnessing of Host Lipids in Bacterial Pathogenesis.

  2016cites this paper
• De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro

  2016cites this paper
• The Future Challenges Facing Antimicrobial Therapy: Resistance and Persistence

  2016cites this paper
• Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum

  2016cites this paper
• Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

  2016cites this paper
• Evaluating TB treatment responses by [18F]FDG-PET/CT imaging

  2016cites this paper
• The Future Challenges Facing Antimicrobial Therapy: Resistance and Persistence

  2016cites this paper
• Translational approaches to predicting tuberculosis risk: from administrative data to transcriptional biomarkers

  2016cites this paper
• Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

  2016cites this paper
• Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA

  2015cites this paper
• Non-genomic Omic Techniques

  2015cites this paper
• Monitoring change in refractive index of cytosol of animal cells on affinity surface under osmotic stimulus for label-free measurement of viability.

  2015cites this paper
• Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis.

  2015cites this paper
• HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic target.

  2015cites this paper
• Investigation of mycobacterial survival in non-permissive growth conditions

  2015cites this paper
• High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo

  2015cites this paper
• Dormancy models for Mycobacterium tuberculosis: A minireview

  2015influential citation
• Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

  2015cites this paper
• A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro

  2015cites this paper
• Sub-Inhibitory Antibiotics Enhance Virulence, Persistence, and Pathogenesis of Uropathogens

  2014cites this paper
• Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media.

  2014cites this paper
• Target identification for prevention and therapy of "Salmonella" infections

  2014cites this paper
• Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states

  2014cites this paper
• Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects

  2014cites this paper
• Latent Tuberculosis: Models, Computational Efforts and the Pathogen’s Regulatory Mechanisms during Dormancy

  2013cites this paper
• A single-cell perspective on non-growing but metabolically active (NGMA) bacteria.

  2013cites this paper
• Tuberculosis: laboratory diagnosis and treatment strategies.

  2013cites this paper
• Pathogenesis of Mycobacterium tuberculosis and its Interaction with the Host Organism

  2013cites this paper
• Reply to “Contradictory Results with High-Dosage Rifamycin in Mice and Humans”

  2013cites this paper
• Studies into the role of peptidoglycan glycolylation in mycobacterial dormancy and resuscitation

  2013cites this paper
• New 2-Thiopyridines as Potential Candidates for Killing both Actively Growing and Dormant Mycobacterium tuberculosis Cells

  2013cites this paper
• Contradictory Results with High-Dosage Rifamycin in Mice and Humans

  2013cites this paper
• Molecular mechanisms of transport and metabolism of vitamin B12 in mycobacteria

  2013cites this paper
• Atmospheric pressure plasma jet for decontamination purposes

  2013cites this paper